See every side of every news story

Published 1 day ago • loading... • Updated 1 day ago

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

Summary by Rockdale Citizen & Newton Citizen

SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation…

31 Articles

31 Articles

The Conway Daily Sun

+30 Reposted by 30 other sources

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation…

1 day ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources31

Leaning Left1Leaning Right5Center14Last Updated3 hours agoBias Distribution

70% Center

Bias Distribution

70% of the sources are Center

70% Center

+9

Untracked bias

+2

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 1 day ago on Monday, August 11, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics